Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2021-09-14 Major Shareholding Noti…
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Mandatory notification of trade in Vistin Pharma ASA  
Major Shareholding Notification Classification · 99% confidence The document text explicitly states 'Mandatory notification of trade' and details the purchase and sale of shares by entities closely associated with a board member (Øystein Stray Spetalen). This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2021-09-14 Norwegian
Vistin Pharma ASA: Second quarter and first half 2021 financial results
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for Vistin Pharma covering the second quarter and first half of 2021. It includes comprehensive financial statements (income statement, balance sheet), operational reviews, management commentary, and shareholder information. It is not an announcement of a report (RPA) because it contains the actual substantive financial data and analysis. It is not an earnings release (ER) because it provides a full set of financial statements and detailed operational analysis rather than just key highlights. Therefore, it is classified as an Interim/Quarterly Report (IR). Q2 2021
2021-08-19 English
Vistin Pharma ASA: Second quarter and first half 2021 financial results
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Vistin Pharma ASA covering the second quarter and first half of 2021. It includes detailed financial statements (P&L, balance sheet, cash flow), management commentary on operational status, market outlook, and risk factors. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. H1 2021
2021-08-19 English
Vistin Pharma ASA: Second quarter and first half 2021 financial results
Earnings Release Classification · 100% confidence The document explicitly states it announces the 'financial results for the second quarter 2021' and provides key financial highlights (Revenue, EBITDA, Net Profit) for that period. This strongly indicates an Earnings Release (ER). Furthermore, the document mentions that the 'Q2 report and presentation' are enclosed and that a conference call will be held today. Because the document is short (2540 chars) and primarily serves to announce the results and the associated call/report availability, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results. It is not the full Interim Report (IR) itself, nor is it just an announcement of the report's publication (RPA), as it contains the actual summary results. Q2 2021
2021-08-19 English
Vistin Pharma ASA: Invitation to Q2 2021 conference call
Report Publication Announcement Classification · 86% confidence The document is titled "Vistin Pharma ASA: Invitation to Q2 2021 conference call" and explicitly states that the company will release its Q2 2021 results on August 19, 2021, followed by a conference call with a Q&A session. This content is an invitation and logistical information for an earnings call, not the transcript of the call itself, nor the full earnings release (ER). Since it provides details for an upcoming conference call where results will be discussed, it is most accurately classified as a Call Transcript (CT) precursor or, more precisely, the announcement related to the call. However, looking at the definitions, 'Call Transcript (Code: CT)' is defined as the 'Full text transcript of company conference calls (like earnings calls with Q&A)'. Since this document is the *invitation* to the call, and not the transcript, it doesn't fit CT perfectly. It is also not an Earnings Release (ER) which is the 'Initial announcement of quarterly/periodical financial results (key highlights only)'. Given the options, the document is announcing the event where the results will be discussed. If the document were the actual transcript, it would be CT. If it were the press release with the numbers, it would be ER. Since it is an invitation to the call where Q&A happens, it is closely related to the call event. However, the most fitting category for an announcement *about* an earnings call, especially one that includes Q&A details, is often grouped with the call itself or the earnings release. Given the short length (1592 chars) and the focus on scheduling the call, it functions as a notification. If we strictly follow the definitions, it is not the transcript (CT) or the initial results release (ER). It is an announcement about the call. Since there is no specific category for 'Conference Call Invitation', and it is not the actual transcript, the closest related category that deals with the discussion of results is CT, but this is a weak fit. Let's re-evaluate based on the 'MENU VS MEAL' rule. This is an announcement *about* the results discussion event. If the document were the actual transcript, it would be CT. If it were the press release, it would be ER. Since it is an invitation to the call, it is a regulatory announcement related to the earnings event. Given the options, and recognizing that the core purpose is to facilitate the discussion of the Q2 results, it is often grouped with the earnings event documentation. Since it is an invitation and not the transcript, and not the highlights release, the fallback 'RNS' might be considered, but let's check if it fits ER better. ER is the 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This document *announces* the release date of the results and the call details. It is highly likely that the actual ER document will follow or accompany this. Because this document is primarily an invitation to the call, and not the results themselves, it is best classified as a general Regulatory Filing (RNS) or potentially a precursor to the ER. However, in many databases, the announcement of the earnings call logistics is often bundled with the ER or CT. Given the strong focus on the Q&A conference call, and the lack of a specific 'Call Announcement' type, I will classify it as a Call Transcript (CT) as it pertains directly to the scheduled call event, acknowledging it's the invitation rather than the transcript itself, or use RNS as the fallback for an announcement that doesn't fit perfectly. Given the context of financial reporting, an invitation to the earnings call is a key event announcement. I will lean towards RNS as the most accurate fallback for a specific event announcement that isn't the report itself or the transcript. Reconsidering: The document explicitly mentions the release of Q2 2021 results and invites people to the conference call where management discussion and Q&A will occur. This is the logistical setup for the earnings discussion. If the actual results highlights were present, it would be ER. Since it's just the invitation, RNS is the safest general regulatory announcement category. I will select RNS as the best fit for a specific logistical announcement that doesn't match the core definitions of ER, CT, or IR.
2021-08-12 English
Vistin Pharma ASA: Ex dividend NOK 0.5 today
Notice of Dividend Amount Classification · 100% confidence The document text is extremely short (194 characters) and explicitly announces a dividend event: 'Ex dividend NOK 0.5 today'. This directly corresponds to the definition of a Notice of Dividend Amount (DIV), which covers the announcement of dividend amounts and payment details.
2021-05-21 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.